30th Sep 2020 12:04
4D Pharma PLC - Leeds-based pharmaceutical company - Loss for the six months to June 30 widens year-on-year to GBP13.7 million from GBP12.0 million. Research and development expenditure rises to GBP12.4 million from GBP10.8 million. Revenue GBP275,000 versus none generated a year ago. Cash and cash equivalents and short-term deposits GBP10 million at June-end.
Current stock price: 153.50 pence
Year-to-date change: up 54%
By Tapan Panchal; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
DDDD.L